Details for New Drug Application (NDA): 200630
✉ Email this page to a colleague
The generic ingredient in TADALAFIL is tadalafil. There are twenty-five drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 200630
Tradename: | TADALAFIL |
Applicant: | Mylan |
Ingredient: | tadalafil |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 200630
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Aug 3, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription